SuperSonic Imagine presented the new version of Aixplorer for the first time at Journées Françaises de Radiologie (JFR) in Paris, Oct. 14-17. The newly released upgrade to Aixplorer, the UltraFast ultrasound system, enhances performance, workflow and efficiency while adding new features.
SyntheticMR AB and Siemens Healthineers have entered into a cooperation agreement, making the SyMRI software packages from SyntheticMR compatible with magnetic resonance imaging (MRI) scanners from Siemens Healthineers and available to their customers.
Researchers have found measurable brain changes in children after a single season of playing youth football, even without a concussion diagnosis, according to a new study published online in the journal Radiology.
Medical imaging informatics involves usage of digital technology to capture medical images, facilitating data analysis to record and correlate observations and draws conclusions that play a vital role in the diagnosis of medical problems. The implementation of electronic health records (EHR) has also spurred increased demand to exchange medical images in the various departments of healthcare settings. This is according to a new market analysis report from Allied Market Research.
Samsung announced in September that the Willis-Knighton Cancer Center in Shreveport, La., added BodyTom CT, the world’s first portable, full-body, 32-slice computed tomography scanner, to its brachytherapy suite.
Augmenix Inc. announced the three-year results from the SpaceOAR System Prostate Cancer US Pivotal Clinical Trial in September at the 2016 annual meeting of the American Society for Radiation Oncology (ASTRO).
Mach7 Technologies announced in September Virginia Commonwealth University Health System Authority (VCU Health) is now leveraging the latest in vendor neutral archive (VNA) technology with the Mach7 Enterprise Imaging Platform.
October 27, 2016 — The National Comprehensive Cancer Network (NCCN) continues to build its library of appropriate use criteria (AUC) and has published NCCN Imaging Appropriate Use Criteria for eight new cancer types.
